EA200701525A1 - Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением - Google Patents
Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождениемInfo
- Publication number
- EA200701525A1 EA200701525A1 EA200701525A EA200701525A EA200701525A1 EA 200701525 A1 EA200701525 A1 EA 200701525A1 EA 200701525 A EA200701525 A EA 200701525A EA 200701525 A EA200701525 A EA 200701525A EA 200701525 A1 EA200701525 A1 EA 200701525A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- terbutaline sulfate
- oral administration
- derivative
- polymeric composition
- mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 229960005105 terbutaline sulfate Drugs 0.000 title abstract 3
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 title abstract 3
- 229920001661 Chitosan Polymers 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229920001285 xanthan gum Polymers 0.000 abstract 2
- 229940082509 xanthan gum Drugs 0.000 abstract 2
- 235000010493 xanthan gum Nutrition 0.000 abstract 2
- 239000000230 xanthan gum Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение направлено на фармацевтическую композицию с контролируемьм высвобождением, обеспечивающую длительное высвобождение основного лекарственного препарата тербуталин сульфата, упомянутая композиция содержит, по меньшей мере, тербуталин сульфат или его производное в качестве активного агента и также содержит неактивную матрицу, причем упомянутая матрица содержит смесь гидрофильных полисахаридных полимеров, причем упомянутая смесь содержит хитозан или его производное и дополнительно содержит ксантановую смолу или ее производное, где соотношение ксантановой смолы и хитозана в упомянутой смеси находится в интервале от около 1:10 до около 10:1, и причем упомянутая композиция, при необходимости, содержит бикарбонат натрия.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05000985A EP1685831B1 (en) | 2005-01-19 | 2005-01-19 | Pharmaceutical polymer composition for oral controlled release delivery of terbutaline sulfate |
| PCT/EP2005/013530 WO2006076951A1 (en) | 2005-01-19 | 2005-12-29 | Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200701525A1 true EA200701525A1 (ru) | 2008-02-28 |
| EA013969B1 EA013969B1 (ru) | 2010-08-30 |
Family
ID=34933362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200701525A EA013969B1 (ru) | 2005-01-19 | 2005-12-29 | Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080206334A1 (ru) |
| EP (2) | EP1685831B1 (ru) |
| KR (1) | KR20070100364A (ru) |
| CN (1) | CN101102756A (ru) |
| AT (1) | ATE355833T1 (ru) |
| BR (1) | BRPI0519622A2 (ru) |
| CA (1) | CA2592269A1 (ru) |
| DE (1) | DE602005000675T2 (ru) |
| EA (1) | EA013969B1 (ru) |
| ES (1) | ES2284088T3 (ru) |
| NO (1) | NO20073850L (ru) |
| WO (1) | WO2006076951A1 (ru) |
| ZA (1) | ZA200705660B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011031620A1 (en) * | 2009-09-11 | 2011-03-17 | Transtech Pharma, Inc. | Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| CN102188399B (zh) * | 2011-04-02 | 2012-12-12 | 南京正科制药有限公司 | 托拉塞米胃漂浮片及其制备方法 |
| CN110057932B (zh) * | 2019-04-22 | 2022-03-15 | 上海旭东海普药业有限公司 | 高效液相色谱分析硫酸特布他林有关物质的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3686275T2 (de) * | 1985-01-11 | 1993-03-18 | Teijin Ltd | Praeparate mit verzoegerter freisetzung. |
| US5620706A (en) * | 1995-04-10 | 1997-04-15 | Universite De Sherbrooke | Polyionic insoluble hydrogels comprising xanthan and chitosan |
-
2005
- 2005-01-19 ES ES05000985T patent/ES2284088T3/es not_active Expired - Lifetime
- 2005-01-19 EP EP05000985A patent/EP1685831B1/en not_active Expired - Lifetime
- 2005-01-19 DE DE602005000675T patent/DE602005000675T2/de not_active Expired - Lifetime
- 2005-01-19 AT AT05000985T patent/ATE355833T1/de not_active IP Right Cessation
- 2005-12-29 US US11/813,301 patent/US20080206334A1/en not_active Abandoned
- 2005-12-29 EA EA200701525A patent/EA013969B1/ru not_active IP Right Cessation
- 2005-12-29 CA CA002592269A patent/CA2592269A1/en not_active Abandoned
- 2005-12-29 ZA ZA200705660A patent/ZA200705660B/xx unknown
- 2005-12-29 WO PCT/EP2005/013530 patent/WO2006076951A1/en not_active Ceased
- 2005-12-29 BR BRPI0519622-1A patent/BRPI0519622A2/pt not_active IP Right Cessation
- 2005-12-29 CN CNA2005800468260A patent/CN101102756A/zh active Pending
- 2005-12-29 KR KR1020077018762A patent/KR20070100364A/ko not_active Ceased
- 2005-12-29 EP EP05820497A patent/EP1838299A1/en not_active Withdrawn
-
2007
- 2007-07-23 NO NO20073850A patent/NO20073850L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0519622A2 (pt) | 2009-02-25 |
| EA013969B1 (ru) | 2010-08-30 |
| EP1685831A1 (en) | 2006-08-02 |
| DE602005000675D1 (de) | 2007-04-19 |
| US20080206334A1 (en) | 2008-08-28 |
| EP1838299A1 (en) | 2007-10-03 |
| ES2284088T3 (es) | 2007-11-01 |
| EP1685831B1 (en) | 2007-03-07 |
| CA2592269A1 (en) | 2006-07-27 |
| DE602005000675T2 (de) | 2007-11-15 |
| ATE355833T1 (de) | 2007-03-15 |
| KR20070100364A (ko) | 2007-10-10 |
| ZA200705660B (en) | 2009-01-28 |
| WO2006076951A1 (en) | 2006-07-27 |
| NO20073850L (no) | 2007-10-10 |
| CN101102756A (zh) | 2008-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414907A (pt) | formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas | |
| EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| HRP20120264T1 (hr) | Farmaceutski sastavi neuroaktivnog steroida i njihove uporabe | |
| WO2007048219A3 (en) | Sustained drug release composition | |
| WO2007123955A3 (en) | Stable hydroalcoholic oral spray formulations and methods | |
| BR0009437A (pt) | Amido pré-gelatinizado em uma formulação de liberação controlada | |
| DE602005013244D1 (de) | Pharmazeutische zusammensetzungen für die kontroll | |
| ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
| NO20092662L (no) | Sammensetning med forlenget frigjoring og fremgangsmate for a produsere det samme | |
| NO20062051L (no) | Farmasoytisk virkestoffinneholdende formulering med belegg | |
| ATE303137T1 (de) | Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit | |
| WO2006008173A3 (en) | Pharmaceutical formulations for inhalation | |
| MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
| WO2007017331A3 (en) | Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin | |
| EA200701525A1 (ru) | Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением | |
| EA200200914A1 (ru) | Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина | |
| BRPI0520209A2 (pt) | agente para a prevenÇço e tratamento de doenÇas do fÍgado contendo derivado de pirazolopirimidina | |
| ATE438385T1 (de) | Pharmazeutische zusammensetzung | |
| ATE390127T1 (de) | Universelle zusammensetzung zur kontrollierten wirkstoffabgabe enthaltend chitosan | |
| BRPI0506630A (pt) | composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada | |
| UA83036C2 (ru) | Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ | |
| BRPI0611526A2 (pt) | composição tópica contendo gelatina | |
| JO2440B1 (en) | Formulation of oral pharmaceutical polymers for controlled release of terbutalate sulfate. | |
| ATE256134T1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |